Trial Profile
A retropsective study evaluating clinical characteristics as well as the anticoagulation treatment patterns of German patients with venous thromboembolism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Phenprocoumon (Primary) ; Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 06 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research